Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > Trading Day: TSX retreats from six-month high

May 11th, 2009

Trading Day: TSX retreats from six-month high

Abstract:
Burnaby-based Tekmira Pharmaceuticals gained 36 cents, or 37 per cent, to $1.33 Monday. The company's nanoparticle delivery technology moves a new class of drugs, RNA interference drugs, that switch off disease-causing genes. Swiss pharmaceutical giant Roche has agreed to pay Tekmira up to $18.4 million US, along with $32 million U.S. in milestone payments and additional royalties if Roche's new drugs receive FDA approval and achieve commercial success. RNA interference research received the 2006 Nobel prize for medicine.

Source:
vancouversun.com

Bookmark:

Related Links

Tekmira Pharmaceuticals

Related News Press

News and information

Beneq’s comprehensive industrial Thin Film Coating Services shorten time to market June 18th, 2013

Research and industry frontrunners gather in Dublin at the EuroNanoForum, Europe’s largest nanotechnology conference June 18th, 2013

Imec presents 4K2K CMOS image sensor together with Panasonic: The co-developed imager sensor chip targets high speed, high resolution imaging applications such as next generation HDTV June 18th, 2013

Which qubit my dear? New method to distinguish between neighbouring quantum bits June 18th, 2013

Investments/IPO's/Splits

Dr. Ben J. Lipps designated as Chairman of the Management Board and Chief Executive Officer of Nanostart-holding MagForce AG June 17th, 2013

Harris & Harris Group Notes Carl Zeiss' Planned Acquisition of Xradia June 13th, 2013

Long Island Capital Alliance Announces Participants for Biotech Technology Transfer Capital Forum: Event to Be Held on June 14 in Collaboration With Cold Spring Harbor Laboratory June 8th, 2013

Iran to Hold Int'l Forum on Nanotechnology Economy (IFNE2013) May 30th, 2013

Nanomedicine

Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013

Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013

Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013

European Technology Platform for Nanomedicine and Nanomed2020 European Consortium Launch the Nanomedicine Award June 17th, 2013

Announcements

Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013

Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013

New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013

Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013

Nanobiotechnology

Iranian Scientists Produce Dynamometer for Nanoparticles, Biocells June 15th, 2013

Shape of nanoparticles points the way toward more targeted drugs: A collaboration of scientists at Sanford-Burnham and the University of California, Santa Barbara, finds that rod-shaped particles, rather than spherical particles, appear more effective at adhering to cells June 10th, 2013

Catching individual molecules in a million with optical antennas inside nano-boxes June 10th, 2013

Whispering light hears liquids talk: University of Illinois researchers build first-ever bridge between optomechanics and microfluidics June 7th, 2013